Patent ID: 9151756
Filing Date: 2015-10-06
Classification: A61K,A61P,C07K,G01N

Abstract:
1. An immunogenic composition comprising an effective amount of: (a) a combination of isolated (i) a CT279 antigen comprising the sequence of SEQ ID NO: 8, an antigen with at least 95% sequence identity to SEQ ID NO: 8, or an immunogenic fragment of SEQ ID NO: 8 that comprises the sequence of SEQ ID NO: 70; and (ii) a CT601 antigen comprising the sequence of SEQ ID NO: 6, an antigen with at least 95% sequence identity to SEQ ID NO: 6, or an immunogenic fragment of SEQ ID NO: 6 that comprises the sequence of SEQ ID NO: 68; and (b) an effective amount of a TH1 and/or TH2 adjuvant.